Beneficial effect of trandolapril on the lifespan of a severe hypertensive model

Hypertension Research

Volumn 24, Issue 5, 2001, Pages 559-564

  Takai, S ^a   Sakonjo, H ^a   Miyazaki, M ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Hypertension; Inhibitor; Lifespan

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; SODIUM ION; TRANDOLAPRIL;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BRAIN; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HEART; HYPERTENSION; KIDNEY; LIFESPAN; MALE; MEASUREMENT; MORTALITY; NONHUMAN; RAT; SODIUM LOAD; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BLOOD PRESSURE; BODY WEIGHT; BRAIN; HYPERTENSION; INDOLES; KIDNEY; MALE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SODIUM CHLORIDE, DIETARY; SURVIVAL ANALYSIS;

EID: 0035169422     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.24.559     Document Type: Article

References (27)

1. Establishment of the stroke-prone spontaneously hypertensive rat (SHR)
2. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect
3. Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist long after treatment withdrawal
4. Cerebral complications of hypertension
5. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: A workshop consensus statement
6. Induction of the proto-oncogene c-jun by angiotensin II
7. Vascular smooth muscle cell hypertrophy vs. hyperplasia: Autocrine transforming growth factor-beta I expression determines growth response to angiotensin II
8. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet
9. Differential regulation of vascular angiotensin I-converting enzyme in hypertension
10. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats
11. Long-term ACE inhibition doubles lifespan of hypertensive rats
12. Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats
13. Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat
14. Failure of probucol to prolong survival in salt-loaded stroke-prone spontaneously hypertensive rats
15. Vascular angiotensin-converting enzyme activity in man and other species
16. Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors
17. Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice
18. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism
19. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I
20. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts
21. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?
22. Can inhibition of the renin-angiotensin system have a cardioprotective effect?
23. Cardioreparation with lisinopril in the management of hypertension and heart failure
24. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
25. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension
26. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats
27. Interactions among ACE, kinins and NO